Anna L Kratz
Professor of Physical Medicine and Rehabilitation, Medical School
Email:
[email protected]
Available to mentor
Anna L Kratz
Professor
Manage Your Profile
Center Memberships
-
Center Membere-Health and Artificial Intelligence Initiative
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Center MemberAI and Digital Health Innovation
Recent Publications
-
Kim J, Kim J, Cuevas H, Kratz A. Current Diabetes Reports, 2026 Dec 1; 26 (1):Journal ArticleApplications of Continuous Glucose Monitoring in Cognitive Research in Diabetes: a Scoping Review
DOI:10.1007/s11892-026-01638-1 PMID: 42560615 -
Tabatabaei A, Sosnoff JJ, Kratz AL. Journal of Pain, 2026 Nov 1; 48:Journal ArticleAssociations of chronic low back pain with disability and health-related quality of life outcomes in people with Multiple Sclerosis: a cross-sectional survey study
DOI:10.1016/j.jpain.2026.106385 PMID: 42447974 -
Kuzu D, Whibley D, Ehde DM, Arewasikporn A, Carlozzi NE, Kratz AL. Rehabil Psychol, 2026 Nov; 71 (4): 588 - 594.Journal ArticleExploring resilience variability in a chronic pain and spinal cord injury sample: A brief report.
DOI:10.1037/rep0000661 PMID: 42530986 -
Mistretta EG, Ehde DM, Turner AP, Alschuler KN, Fritz NE, Kratz AL. Archives of Physical Medicine and Rehabilitation, 2026 Oct 1; 107 (10): 2737 - 2745.Journal ArticleDoes Depressed Mood Affect Accuracy of Perceptions of Cognitive Function in Multiple Sclerosis? The Role of Momentary Depressive Symptoms in the Correspondence Between Subjective and Objective Cognition in Multiple Sclerosis
DOI:10.1016/j.apmr.2026.05.004 PMID: 42150724 -
Kim J, Richardson JK, Ehde DM, Abou L, Alschuler KN, Fritz NE, Kratz AL. Multiple Sclerosis and Related Disorders, 2026 Oct 1; 114:Journal ArticlePsychometric evaluation of the ReacStick: A feasible and valid tool for assessing processing speed and executive function in multiple sclerosis
DOI:10.1016/j.msard.2026.107884 PMID: 42679676 -
Kim J, Ehde DM, Ng YT, Janevic MR, VanNostrand M, Alschuler KN, Fritz NE, Kratz AL. Multiple Sclerosis and Related Disorders, 2026 Oct 1; 114:Journal ArticleSocial and socioeconomic factors and cognitive outcomes in multiple sclerosis
DOI:10.1016/j.msard.2026.107440 PMID: 42600506 -
Hernandez R, Schneider S, Hoogendoorn CJ, Kratz AL, Yang C-H, Ehde DM, Stone AA, Jin H, Fanning J, Hakun JG, Fritz NE, Gonzalez JS, Moore RC. Communications Psychology, 2026 Sep 19;Journal ArticleFatigue and processing speed predict subsequent fatigue override, evidence from a coordinated analysis of six EMA studies
DOI:10.1038/s44271-026-00537-1 -
Meurer WJ, Yeatts SD, Geocadin RG, Roy A, Callaway CW, Ramakrishnan V, Berry SM, Caveney AF, Meyer S, Bozeman N, Harney DM, Speers M, Stevenson VLW, Sozener CB, Daya MR, Beiser DG, Elmer J, Khan IR, Hirsch KG, Kilgannon JH, Nassal M, Johnson NJ, Beekman R, May TL, Brown J, Silbergleit R, Difiore-Sprouse S, Darby J, Doshi A, Drumheller B, Faiver L, Flickinger K, Guyette F, Kaynar A, Molyneaux B, Ratay C, Steinberg A, Tam J, Weissman A, Coppler P, Case N, Strusinska-Thayer M, Le N, Smith J, Cook J, Lupton J, Spurlock W, Kim J, Mouammar M, Neth M, Mcconnell K, Roy S, Sabeh M, Kassir A, Paul J, Molignoni K, Peterson LK, Puri N, Remboski L, Jones C, Kurowsky D, Mchugh D, Stewart R, George B, Banker C, Kamal D, Wood N, Proctor A, Adler D, Acidera J, Fuentes M, Elkort K, Katsandres S, Srinivasan V, Thompson K, Kudenchuk P, Kampp M, Gilmore E, Wira C, Jasak S, Kisken K, Kitlen E, Perman S, D'Onofrio G, Meehl K, Gentile N, Reimer H, Isenberg D, Abboud MT, Gezalian M, Lahiri S, Toosi S, Na SM, Cha J, Obialisi G, Ayodele M, Torbati S, Wilburn J, Buck L, Mazzocco T. JAMA, 2026 Sep 8; 336 (10): 857 - 867.Journal ArticleDuration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest The ICECAP Randomized Clinical Trial
DOI:10.1001/jama.2026.10247 PMID: 42554995
Featured News & Stories
Health Lab
Psychoactive substances and adverse side effects for patients with multiple sclerosis
Psychoactive substances can give immediate relief to people living with multiple sclerosis, but some come with adverse side effects. Research led by University of Michigan Health looks at the positive and negative impacts of using psychoactive substances to manage symptoms.
Health Lab
For multiple sclerosis, medication and cognitive behavioral therapy can reduce fatigue
In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue.
